Paul Amminger

Favorable effects of omega-3 polyunsaturated fatty acids in attentional control and conversion rate to psychosis in 22q11.2 deletion syndrome.

Marco Armando, Mariasole Ciampoli, Maria Carmela Padula, Paul Amminger, Franco De Crescenzo, Johanna Maeder, Maude Schneider, Marie Schaer, Francesca Managò, Stephan Eliez, Francesco Papaleo

Journal article  |  2020  |  Neuropharmacology

Omega-3-polyunsaturated-fatty-acids were suggested against cognitive dysfunctions and conversion to psychosis. However, a recent m..

Cross-sectional association of seafood consumption, polyunsaturated fatty acids and depressive symptoms in two Torres Strait communities

Maximus Berger, Sean Taylor, Linton Harriss, Sandra Campbell, Fintan Thompson, Samuel Jones, Maria Makrides, Robert Gibson, G Paul Amminger, Zoltan Sarnyai, Robyn McDermott

Journal article  |  2020  |  Nutritional Neuroscience

Background Dietary intake of long-chain omega 3 (n-3) polyunsaturated fatty acids (LCPUFA) represents a putative modifiable risk f..

Evidence for preventive treatments in young patients at clinical high risk of psychosis: the need for context

Barnaby Nelson, Gunter P Amminger, Andreas Bechdolf, Paul French, Ashok Malla, Anthony P Morrison, Stefanie J Schmidt, Jai L Shah, Andrew Thompson, Mark Van der Gaag, Stephen J Wood, Scott W Woods, Alison R Yung, Patrick D McGorry

Journal article  |  2020  |  The Lancet Psychiatry

Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial.

Sumudu Rasangi Mallawaarachchi, G Paul Amminger, John Farhall, Luke K Bolt, Barnaby Nelson, Hok Pan Yuen, Patrick D McGorry, Connie Markulev, Miriam R Schäfer, Nilufar Mossaheb, Monika Schlögelhofer, Stefan Smesny, Ian B Hickie, Gregor Emanuel Berger, Eric YH Chen, Lieuwe de Haan, Dorien H Nieman, Merete Nordentoft, Anita Riecher-Rössler, Swapna Verma, et al.

Journal article  |  2020  |  Schizophrenia Research

Neurocognitive impairments are well established in both ultra-high risk (UHR) for psychosis and major depressive disorder (MDD). D..

Distress related to attenuated psychotic symptoms: Static and dynamic association with transition to psychosis, non-remission and transdiagnostic symptomatology in clinical high-risk patients in an international intervention trial.

B Nelson, HP Yuen, GP Amminger, G Berger, EYH Chen, L de Haan, JA Hartmann, IB Hickie, S Lavoie, C Markulev, N Mossaheb, DH Nieman, M Nordentoft, A Polari, A Riecher-Rössler, MR Schäfer, M Schlögelhofer, S Smesny, A Tedja, A Thompson, et al.

Journal article  |  2020  |  Schizophrenia Bulletin Open

This study examined whether distress in relation to attenuated psychotic symptoms (DAPS) is associated with clinical outcomes in a..

Association of Adverse Outcomes With Emotion Processing and Its Neural Substrate in Individuals at Clinical High Risk for Psychosis

Gemma Modinos, Matthew J Kempton, Stefania Tognin, Maria Calem, Lilla Porffy, Mathilde Antoniades, Ava Mason, Matilda Azis, Paul Allen, Barnaby Nelson, Patrick McGorry, Christos Pantelis, Anita Riecher-Rossler, Stefan Borgwardt, Rodrigo Bressan, Neus Barrantes-Vidal, Marie-Odile Krebs, Merete Nordentoft, Birte Glenthoj, Stephan Ruhrmann, et al.

Journal article  |  2020  |  JAMA Psychiatry

Importance: The development of adverse clinical outcomes in patients with psychosis has been associated with behavioral and neuroa..

Global research priorities for youth mental health

Cristina Mei, Joanna Fitzsimons, Nicholas Allen, Mario Alvarez-Jimenez, Gunter Paul Amminger, Vivienne Browne, Mary Cannon, Maryann Davis, Barbara Dooley, Ian B Hickie, Srividya Iyer, Eoin Killackey, Ashok Malla, Ian Manion, Steve Mathias, Kerryn Pennell, Rosemary Purcell, Debra Rickwood, Swaran P Singh, Stephen J Wood, et al.

Journal article  |  2020  |  Early Intervention in Psychiatry

AIM: Over the past two decades, the youth mental health field has expanded and advanced considerably. Yet, mental disorders contin..

The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis

G Paul Amminger, Barnaby Nelson, Connie Markulev, Hok Pan Yuen, Miriam R Schafer, Maximus Berger, Nilufar Mossaheb, Monika Schloegelhofer, Stephan Smesny, Ian B Hickie, Gregor E Berger, Eric YH Chen, Lieuwe de Haan, Dorien H Nieman, Merete Nordentoft, Anita Riecher-Roessler, Swapna Verma, Andrew Thompson, Alison Ruth Yung, Patrick D McGorry

Journal article  |  2020  |  Biological Psychiatry

BACKGROUND: NEURAPRO was a multicenter, placebo-controlled trial of long-chain omega-3 polyunsaturated fatty acids (n-3 PUFAs) (fi..

Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirin

Michael Berk, Mohammadreza Mohebbi, Olivia M Dean, Sue M Cotton, Andrew M Chanen, Seetal Dodd, Aswin Ratheesh, G Paul Amminger, Mark Phelan, Amber Weller, Andrew Mackinnon, Francesco Giorlando, Shelley Baird, Lisa Incerti, Rachel E Brodie, Natalie O Ferguson, Simon Rice, Miriam R Schafer, Edward Mullen, Sarah Hetrick, et al.

Journal article  |  2020  |  BMC Medicine

BACKGROUND: Inflammation contributes to the pathophysiology of major depressive disorder (MDD), and anti-inflammatory strategies m..

Novel Modalities for Assessment and Intervention in Youth Mental Health Digital Interventions and Omega-3 Fatty Acid

M Alvarez-Jimenez, G Paul Amminger, Maximus Berger, J Gleeson, Andrew Chanen

Book Chapter  |  2020

Harmonised collection of data in youth mental health: Towards large datasets

Suzie Lavoie, Kelly Allott, Paul Amminger, Cali Bartholomeusz, Maximus Berger, Michael Breakspear, Anjali K Henders, Rico Lee, Ashleigh Lin, Patrick McGorry, Simon Rice, Lianne Schmaal, Stephen J Wood

Journal article  |  2020  |  Australian & New Zealand Journal of Psychiatry

OBJECTIVE: The current international trend is to create large datasets with existing data and/or deposit newly collected data into..

Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial

Jessica A Hartmann, Stefanie J Schmidt, Patrick D McGorry, Maximus Berger, Gregor E Berger, Eric YH Chen, Lieuwe de Haan, Ian B Hickie, Suzie Lavoie, Connie Markulev, Nilufar Mossaheb, Dorien H Nieman, Merete Nordentoft, Andrea Polari, Anita Riecher-Rossler, Miriam R Schafer, Monika Schlogelhofer, Stefan Smesny, Andrew Thompson, Swapna K Verma, et al.

Journal article  |  2020  |  Behaviour Research and Therapy

The Ultra-High Risk (UHR) for psychosis group is known to be heterogeneous with diverse outcomes. This study aimed to: 1. Identify..

The prognostic significance of attenuated psychotic symptoms in help-seeking youth

H Hazan, T Spelman, GP Amminger, I Hickie, PD McGorry, LJ Phillips, R Purcell, SJ Wood, AR Yung, B Nelson

Journal article  |  2020  |  Schizophrenia Research

BACKGROUND: Recent findings suggest that attenuated psychotic symptoms (APS) might serve as a risk factor for general mental healt..

Basic symptoms in young people at ultra-high risk of psychosis: Association with clinical characteristics and outcomes.

S Youn, LJ Phillips, GP Amminger, G Berger, EYH Chen, L de Haan, JA Hartmann, IB Hickie, S Lavoie, C Markulev, PD McGorry, N Mossaheb, DH Nieman, M Nordentoft, A Riecher-Rössler, MR Schäfer, M Schlögelhofer, S Smesny, A Thompson, S Verma, et al.

Journal article  |  2019  |  Schizophrenia Research

There has been limited research into the predictive value of basic symptoms and their relationship with other psychopathology in p..

Can antipsychotic dose reduction lead to better functional recovery in first-episode psychosis? A randomized controlled-trial of antipsychotic dose reduction. The reduce trial: Study protocol

Amber Weller, John Gleeson, Mario Alvarez-Jimenez, Patrick McGorry, Barnaby Nelson, Kelly Allott, Sarah Bendall, Cali Bartholomeusz, Peter Koval, Susy Harrigan, Brian O'Donoghue, Alex Fornito, Christos Pantelis, G Paul Amminger, Aswin Ratheesh, Andrea Polari, Stephen J Wood, Kristi van der El, Carli Ellinghaus, Jesse Gates, et al.

Journal article  |  2019  |  Early Intervention in Psychiatry

Antipsychotic medication has been the mainstay of treatment for psychotic illnesses for over 60 years. This has been associated wi..

ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis

SM Cotton, M Berk, A Watson, S Wood, K Allott, CF Bartholomeusz, CC Bortolasci, K Walder, B O'Donoghue, OM Dean, A Chanen, GP Amminger, PD McGorry, A Burnside, J Uren, A Ratheesh, S Dodd

Journal article  |  2019  |  Trials

BACKGROUND: First-episode psychosis (FEP) may lead to a progressive, potentially disabling and lifelong chronic illness; however, ..

Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis.

Ayedh Alqarni, Todd W Mitchell, Patrick D McGorry, Barnaby Nelson, Connie Markulev, Hok Pan Yuen, Miriam R Schäfer, Maximus Berger, Nilufar Mossaheb, Monika Schlögelhofer, Stephan Smesny, Ian B Hickie, Gregor E Berger, Eric YH Chen, Lieuwe de Haan, Dorien H Nieman, Merete Nordentoft, Anita Riecher-Rössler, Swapna Verma, Andrew Thompson, et al.

Journal article  |  2019  |  Schizophrenia Research

Omega-3 long chain polyunsaturated fatty acids (n-3 LCPUFA) are necessary for optimum mental health, with recent studies showing l..

Can youth at high risk of illness progression be identified by measures of rumination and sleep-wake disturbance

Ashlee B Grierson, Jan Scott, Nick Glozier, Ian B Hickie, Paul G Amminger, Eoin Killackey, Patrick D McGorry, Christos Pantelis, Lisa Phillips, Elizabeth Scott, Alison R Yung, Rosemary Purcell

Journal article  |  2019  |  Early Intervention in Psychiatry

AIM: Clinical staging models offer a useful framework for understanding illness trajectories, where individuals are located on a c..

The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial

Christopher G Davey, Andrew M Chanen, Sarah E Hetrick, Sue M Cotton, Aswin Ratheesh, Guenter P Amminger, John Koutsogiannis, Mark Phelan, Edward Mullen, Ben J Harrison, Simon Rice, Alexendra G Parker, Olivia M Dean, Amber Weller, Melissa Kerr, Amelia L Quinn, Lisa Catania, Nikolaos Kazantzis, Patrick D McGarry, Michael Berk

Journal article  |  2019  |  The Lancet Psychiatry

Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people.

Ayedh Alqarni, Todd W Mitchell, Patrick D McGorry, Barnaby Nelson, Connie Markulev, Hok Pan Yuen, Miriam R Schäfer, Maximus Berger, Nilufar Mossaheb, Monika Schlögelhofer, Stefan Smesny, Ian B Hickie, Gregor E Berger, Eric YH Chen, Lieuwe de Haan, Dorien H Nieman, Merete Nordentoft, Anita Riecher-Rössler, Swapna Verma, Andrew Thompson, et al.

Journal article  |  2019  |  Schizophrenia Research

People classified as ultra-high risk (UHR) of developing psychosis have reduced cellular membrane omega-3 and omega-6 polyunsatura..

Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial

Maximus Berger, Barnaby Nelson, Connie Markulev, Hok Pan Yuen, Miriam R Schafer, Nilufar Mossaheb, Monika Schloegelhofer, Stefan Smesny, Ian B Hickie, Gregor E Berger, Eric YH Chen, Lieuwe de Haan, Dorien H Nieman, Merete Nordentoft, Anita Riecher-Rossler, Swapna Verma, Andrew Thompson, Alison Ruth Yung, Patrick D McGorry, G Paul Amminger

Journal article  |  2019  |  Frontiers in Psychiatry

Frontal slow wave resting EEG power is higher in individuals at Ultra High Risk for psychosis than in healthy controls but is not associated with negative symptoms or functioning

Miranda Sollychin, Bradley N Jack, Andrea Polari, Ayaka Ando, G Paul Amminger, Connie Markulev, Patrick D McGorry, Barnaby Nelson, Thomas J Whitford, Hok Pan Yuen, Suzie Lavoie

Journal article  |  2019  |  Schizophrenia Research

Broad clinical high-risk mental state (CHARMS): Methodology of a cohort study validating criteria for pluripotent risk

Jessica A Hartmann, Barnaby Nelson, Rachael Spooner, G Paul Amminger, Andrew Chanen, Christopher G Davey, Meredith McHugh, Aswin Ratheesh, Devi Treen, Hok Pan Yuen, Patrick D McGorry

Journal article  |  2019  |  Early Intervention in Psychiatry

Gender differences of patients at-risk for psychosis regarding symptomatology, drug use, comorbidity and functioning - Results from the EU-GEI study

Stephanie Menghini-Mueller, Erich Studerus, Sarah Ittig, Ulrike Heitz, Laura Egloff, Christina Andreou, Lucia R Valmaggia, Matthew J Kempton, Mark van der Gaag, Lieuwe de Haan, Barnaby Nelson, Neus Barrantes-Vidal, Merete Nordentoft, Stephan Ruhrmann, Gabriele Sachs, Bart P Rutten, Jim van Os, Anita Riecher-Rossler, Philip McGuire, Maria Calem, et al.

Journal article  |  2019  |  European Psychiatry

Hair cortisol, allostatic load, and depressive symptoms in Australian Aboriginal and Torres Strait Islander people

Maximus Berger, Sean Taylor, Linton Harriss, Sandra Campbell, Fintan Thompson, Samuel Jones, Ashleigh Sushames, G Paul Amminger, Zoltan Sarnyai, Robyn McDermott

Journal article  |  2019  |  Stress

Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial

Luke K Bolt, G Paul Amminger, John Farhall, Patrick D McGorry, Barnaby Nelson, Connie Markulev, Hok Pan Yuen, Miriam R Schafer, Nilufar Mossaheb, Monika Schlogelhofer, Stefan Smesny, Ian B Hickie, Gregor Emanuel Berger, Eric YH Chen, Lieuwe de Haan, Dorien H Nieman, Merete Nordentoft, Anita Riecher-Roessler, Swapna Verma, Andrew Thompson, et al.

Journal article  |  2019  |  Schizophrenia Research

Youth depression alleviation with anti-inflammatory agents (YoDA-A): A placebo-controlled randomised augmentation trial of rosuvastatin and aspirin

M Berk, M Mohammadreza, OM Dean, SM Cotton, AM Chanen, S Dodd, A Ratheesh, GP Amminger, M Phelan, A Williams, A Mackinnon, F Giorlando, S Baird, S Rice, M O'Shea, MR Schafer, E Mullen, S Hetrick, M Kerr, SM Harrigan, et al.

Conference Proceedings  |  2019  |  BIPOLAR DISORDERS

The addition of fluoxetine to cognitive behavioural therapy for youth depression: The YoDA-C randomised clinical trial

CG Davey, S Hetrick, AM Chanen, SM Cotton, A Ratheesh, GP Amminger, J Koutsogiannis, M Phelan, E Mullen, BJ Harrison, S Rice, A Williams, M Kerr, AL Quinn, S Baird, N Ferguson, R Brodie, L Incerti, OM Dean, PD McGorry, et al.

Conference Proceedings  |  2019  |  BIPOLAR DISORDERS

Current versus recently resolved attenuated psychotic symptoms: Same level of risk for transition to psychosis?

Simon M Rice, Patrick D McGorry, G Paul Amminger, Barnaby Nelson

Journal article  |  2019  |  Schizophrenia Research

The relationship between childhood trauma and clinical characteristics in ultra-high risk for psychosis youth

Chloe de Vos, Andrew Thompson, Paul Amminger, Sarah Bendall, Lieuwe de Haan, Jessica Hartmann, Suzie Lavoie, Connie Markulev, Patrick McGorry, Dorien Nieman, Lisa Phillips, Ulrich Reininghaus, Hok Pan Yuen, Alison Yung, Barnaby Nelson

Journal article  |  2019  |  Psychosis

Chapter 9 – Novel Treatment Strategies: Biological

G Paul Amminger, Maximus Berger

Book Chapter  |  2019

Dynamic prediction of transition to psychosis using joint modelling

HP Yuen, A Mackinnon, J Hartmann, GP Amminger, C Markulev, S Lavoie, MR Schaefer, A Polari, N Mossaheb, M Schloegelhofer, S Smesny, IB Hickie, G Berger, EYH Chen, L de Haan, DH Nieman, M Nordentoft, A Riecher-Roessler, S Verma, A Thompson, et al.

Journal article  |  2018  |  Schizophrenia Research

Latent Iron Deficiency as a Marker of Negative Symptoms in Patients with First-Episode Schizophrenia Spectrum Disorder

Sung-Wan Kim, Robert Stewart, Woo-Young Park, Min Jhon, Ju-Yeon Lee, Seon-Young Kim, Jae-Min Kim, Paul Amminger, Young-Chul Chung, Jin-Sang Yoon

Journal article  |  2018  |  Nutrients

Relationship between allostatic load and clinical outcomes in youth at ultra-high risk for psychosis in the NEURAPRO study.

Maximus Berger, Suzie Lavoie, Patrick D McGorry, Barnaby Nelson, Connie Markulev, Hok-Pan Yuen, Miriam Schaefer, Zoltán Sarnyai, G Paul Amminger

Journal article  |  2018  |  Schizophrenia Research

Individuals at ultra-high risk (UHR) for psychosis have an elevated risk of developing psychosis and other psychiatric outcomes. R..

Recent Meta-Analyses in the Clinical High Risk for Psychosis Population: Clinical Interpretation of Findings and Suggestions for Future Research

Barnaby Nelson, Gunter Paul Amminger, Patrick Denistoon McGorry

Journal article  |  2018  |  Frontiers in Psychiatry

Omega-3 Polyunsaturated Fatty Acids improve neurocognitive functions and reduce the conversion rate of psychosis in patients with 22q11.2 deletion syndrome

Marco Armando, Maria Carmela Padula, Franco De Crescenzo, Maude Schneider, Paul Amminger, Marie Schaer, Stephan Eliez

Conference Proceedings  |  2018  |  EARLY INTERVENTION IN PSYCHIATRY

Improving Mental Health in Young People through Harmonised Collection of Data

Suzie Lavoie, Kelly Allott, Paul Amminger, Maximus Berger, Michael Breakspear, Anjali Henders, Rico Lee, Ashleigh Lin, Patrick McGorry, Simon Rice, Lianne Schmaal, Stephen Wood

Conference Proceedings  |  2018  |  EARLY INTERVENTION IN PSYCHIATRY

Baseline Omega-3 Fatty Acids in Erythrocytes as Predictors of Functional and Clinical Outcomes in People at Ultra-High Risk for Psychosis

G Paul Amminger, Barnaby Nelson, Connie Markulev, Hok Pan Yuen, Miriam R Schafer, Nilufar Mossaheb, Monika Schlogelhofer, Stefan Smesny, Ian B Hickie, Gregor E Berger, Eric YH Chen, Lieuwe de Haan, Dorien H Nieman, Merete Nordentoft, Anita Riecher-Rossler, Swapna Verma, Maximus Berger, Andrew Thompson, Alison R Yung, Patrick D McGorry

Conference Proceedings  |  2018  |  EARLY INTERVENTION IN PSYCHIATRY

Broadening the Scope: A Pluripotential At-Risk Mental State

Jessica Hartmann, Barnaby Nelson, Rachael Spooner, G Paul Amminger, Andrew Chanen, Aswin Ratheesh, Christopher Davey, Patrick McGorry

Conference Proceedings  |  2018  |  EARLY INTERVENTION IN PSYCHIATRY

Clinical Prediction Besides Transition to Psychosis in the Ultra-High Risk for Psychosis Population

Andrea Polari, Suzie Lavoie, Hok Pan Yuen, Paul Amminger, Gregor Berger, Eric Chen, Lieuwe deHaan, Jessica Hartmann, Connie Markulev, Dorien Nieman, Merete Nordentoft

Conference Proceedings  |  2018  |  EARLY INTERVENTION IN PSYCHIATRY

A Novel Approach to Developing a Prediction Model of Transition to Psychosis: Dynamic Prediction Using Joint Modelling

Hok Pan Yuen, Andrew Mackinnon, Patrick McGorry, G Paul Amminger, Jessica Hartmann, Miriam Schafer, Connie Markulev, Suzie Lavoie, Barnaby Nelson

Conference Proceedings  |  2018  |  EARLY INTERVENTION IN PSYCHIATRY

Disturbed glutathione antioxidative defense is associated with structural brain changes in neuroleptic-naive first-episode psychosis patients

K Langbein, J Hesse, A Gussew, B Milleit, S Lavoie, GP Amminger, C Gaser, G Wagner, JR Reichenbach, U-C Hipler, D Winter, S Smesny

Journal article  |  2018  |  Prostaglandins, Leukotrienes and Essential Fatty Acids

Resting-state functional brain networks in first-episode psychosis: A 12-month follow-up study

Eleni P Ganella, Caio Seguin, Christos Pantelis, Sarah Whittle, Bernhard T Baune, James Olver, G Paul Amminger, Patrick D McGorry, Vanessa Cropley, Andrew Zalesky, Cali F Bartholomeusz

Journal article  |  2018  |  Australian & New Zealand Journal of Psychiatry

Clinical trajectories in the ultra-high risk for psychosis population

Andrea Polari, Suzie Lavoie, Hok-Pan Yuen, Paul Amminger, Gregor Berger, Eric Chen, Lieuwe deHaan, Jessica Hartmann, Connie Markulev, Fritha Melville, Dorien Nieman, Merete Nordentoft, Anita Riecher-Rossler, Stefan Smesny, John Stratford, Swapna Verma, Alison Yung, Patrick McGorry, Barnaby Nelson

Journal article  |  2018  |  Schizophrenia Research

Duration of untreated psychosis and neurocognitive functioning in first-episode psychosis: a systematic review and meta-analysis

K Allott, D Fraguas, CF Bartholomeusz, CM Diaz-Caneja, C Wannan, EM Parrish, GP Amminger, C Pantelis, C Arango, PD McGorry, M Rapado-Castro

Journal article  |  2018  |  Psychological Medicine

NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders-medium-term follow-up and clinical course.

B Nelson, GP Amminger, HP Yuen, C Markulev, S Lavoie, MR Schäfer, JA Hartmann, N Mossaheb, M Schlögelhofer, S Smesny, IB Hickie, G Berger, EYH Chen, L de Haan, DH Nieman, M Nordentoft, A Riecher-Rössler, S Verma, A Thompson, AR Yung, et al.

Journal article  |  2018  |  npj Schizophrenia

This study reports a medium-term follow-up of a randomised, double-blind, placebo-controlled trial of omega-3 polyunsaturated fatt..

Staged Treatment in Early Psychosis: A sequential multiple assignment randomised trial of interventions for ultra high risk of psychosis patients

Barnaby Nelson, G Paul Amminger, Hok Pan Yuen, Nicky Wallis, Melissa J Kerr, Lisa Dixon, Cameron Carter, Rachel Loewy, Tara A Niendam, Martha Shumway, Sarah Morris, Julie Blasioli, Patrick D McGorry

Journal article  |  2018  |  Early Intervention in Psychiatry

The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo

MJ McHugh, PD McGorry, HP Yuen, IB Hickie, A Thompson, L de Haan, N Mossaheb, S Smesny, A Lin, C Markulev, M Schloegelhofer, SJ Wood, D Nieman, JA Hartmann, M Nordentoft, M Schafer, GP Amminger, A Yung, B Nelson

Journal article  |  2018  |  Schizophrenia Research

Child Maltreatment and Clinical Outcome in Individuals at Ultra-High Risk for Psychosis in the EU-GEI High Risk Study

Tamar C Kraan, Eva Velthorst, Manouk Themmen, Lucia Valmaggia, Matthew J Kempton, Phillip McGuire, Jim van Os, Bart PF Rutten, Filip Smit, Lieuwe de Haan, Mark van der Gaag

Journal article  |  2018  |  Schizophrenia Bulletin

ASSOCIATION BETWEEN VITAMIN D INSUFFICIENCY AND METABOLIC SYNDROME IN PATIENTS WITH PSYCHOTIC DISORDERS

Sung-Wan Kim, Taeyoung Yoo, Jung Jin Kim, Jae-Kyeong Kim, Ji-Eun Hong, Ju-Yeon Lee, Jae-Min Kim, G Paul Amminger, Michael Berk, Jin-Sang Yoon

Conference Proceedings  |  2018  |  SCHIZOPHRENIA BULLETIN

NEUROCOGNITION IN ULTRA-HIGHRISK INDIVIDUALS AND RELATIONSHIP TO TRANSITION TO PSYCHOSIS, DEPRESSIVE DISORDER, AND FUNCTIONING: FINDINGS FROM THE NEURAPRO TRIAL

Kelly Allott, Patrick McGorry, Luke Bolt, Barnaby Nelson, Connie Markulev, Hok Pan Yuen, Miriam Schaefer, Nilufar Mossaheb, Monika Schloegelhofer, Stephan Smesny, Ian Hickie, Gregor Berger, Eric Chen, Lieuwe De Haan, Dorien Nieman, Merete Nordentoft, Anita Riecher-Rossler, Swapna Verma, Andrew Thompson, Alison Yung, et al.

Conference Proceedings  |  2018  |  SCHIZOPHRENIA BULLETIN

Allostatic load is associated with psychotic symptoms and decreases with antipsychotic treatment in patients with schizophrenia and first-episode psychosis

Maximus Berger, Robert-Paul Juster, Sabine Westphal, G Paul Amminger, Bernhard Bogerts, Kolja Schiltz, Sabine Bahn, Johann Steiner, Zoltan Sarnyai

Journal article  |  2018  |  Psychoneuroendocrinology

RELATIONSHIP BETWEEN ALLOSTATIC LOAD AND POOR FUNCTIONAL CAPACITY IN YOUTH AT ULTRA-HIGH RISK FOR PSYCHOSIS

Maximus Berger, Suzie Lavoie, Patrick D McGorry, Barnaby Nelson, Connie Markulev, Hok Pan Yuen, Miriam Schaefer, Zoltan Sarnyai, G Paul Amminger

Conference Proceedings  |  2018  |  SCHIZOPHRENIA BULLETIN

A NOVEL APPROACH FOR DEVELOPING PREDICTION MODEL OF TRANSITION TO PSYCHOSIS: DYNAMIC PREDICTION USING JOINT MODELLING

Hok Pan Yuen, Andrew Mackinnon, Jessica Hartmann, Paul Amminger, Connie Markulev, Suzie Lavoie, Miriam Schafer, Andrea Polari, Nilufar Mossaheb, Monika Schlogelhofer, Stefan Smesny, Ian Hickie, Gregor Berger, Eric Chen, Lieuwe de Hann, Dorien Nieman, Merete Nordentoft, Anita Riecher-Rossler, Swapna Verma, Andrew Thompson, et al.

Conference Proceedings  |  2018  |  SCHIZOPHRENIA BULLETIN

NEURAPRO REVISITED: INCREASES IN LONG-CHAIN OMEGA-3 FATTY ACIDS IMPROVE FUNCTIONAL AND SYMPTOMATIC OUTCOMES IN ULTRAHIGH RISK PATIENTS

G Paul Amminger, Barnaby Nelson, Hok Pan Yuen, Connie Markulev, Miriam R Schaefer, Monika Schloegelhofer, Nilufar Mossaheb, Stephan Smesny, Ian Hickie, Gregor Berger, Eric Chen, Lieuwe de Haan, Dorien H Nieman, Merete Nordentoft, Anita Riecher-Roessler, Swapna Verma, Maximus Berger, Andrew Thompson, Alison Yung, Patrick D McGorry

Conference Proceedings  |  2018  |  SCHIZOPHRENIA BULLETIN

THE NEURAPRO STUDY: ADHERENCE TO STUDY MEDICATION

Monika Schloegelhofer, Patrick D McGorry, Barnaby Nelson, Connie Markulev, Hok Pan Yuen, Miriam Schaefer, Nilufar Mossaheb, Stefan Smesny, Ian B Hickie, Gregor Berger, Eric YH Chen, Lieuwe de Haan, Dorien H Nieman, Merete Nordentoft, Anita Riecher-Roessler, Swapna Verma, Andrew Thompson, Alison Ruth Yung, G Paul Amminger

Conference Proceedings  |  2018  |  SCHIZOPHRENIA BULLETIN

Association Between Vitamin D Insufficiency and Metabolic Syndrome in Patients With Psychotic Disorders

Taeyoung Yoo, Wonsuk Choi, Jin-Hee Hong, Ju-Yeon Lee, Jae-Min Kim, Il-Seon Shin, Soo Jin Yang, Paul Amminger, Michael Berk, Jin-Sang Yoon, Sung-Wan Kim

Journal article  |  2018  |  Psychiatry Investigation

CROSS-SECTIONAL ASSOCIATION OF MEMBRANE FATTY ACID COMPOSITION AND PSYCHOPATHOLOGY IN THE NEURAPRO-E STUDY

Maximus Berger, Patrick D McGorry, Barnaby Nelson, Connie Markulev, Hok Pan Yuen, Miriam Schaefer, Nilufar Mossaheb, Monika Schlogelhofer, Stefan Smesny, Ian Hickie, Gregor Berger, Eric Chen, Lieuwe De Haan, Dorien Nieman, Merete Nordentoft, Anita Riecher-Rossler, Swapna Verma, Andrew Thompson, Alison Yung, G Paul Amminger

Conference Proceedings  |  2018  |  SCHIZOPHRENIA BULLETIN

A PLURIPOTENTIAL AT RISK MENTAL STATE: INITIAL RESULTS

Jessica A Hartmann, Barnaby Nelson, Spooner Rachael, G Paul Amminger, Andrew Chanen, Aswin Ratheesh, Christopher G Davey, Patrick D McGorry

Conference Proceedings  |  2018  |  SCHIZOPHRENIA BULLETIN

Predictors of longer-term outcome in the Vienna omega-3 high-risk study

Nilufar Mossaheb, Miriam R Schaefer, Monika Schloegelhofer, Claudia M Klier, Stefan Smesny, Patrick D McGorry, Maximus Berger, G Paul Amminger

Journal article  |  2018  |  Schizophrenia Research

In vivo imaging of oxidative stress and fronto-limbic white matter integrity in young adults with mood disorders

Daniel F Hermens, Sean N Hatton, Rico SC Lee, Sharon L Naismith, Shantel L Duffy, G Paul Amminger, Manreena Kaur, Elizabeth M Scott, Jim Lagopoulos, Ian B Hickie

Journal article  |  2018  |  European Archives of Psychiatry and Clinical Neuroscience

Changes in triglyceride levels in ultra-high risk for psychosis individuals treated with omega-3 fatty acids

Nilufar Mossaheb, Konstantinos Papageorgiou, Miriam R Schaefer, Jana Becker, Monika Schloegelhofer, G Paul Amminger

Journal article  |  2018  |  Early Intervention in Psychiatry

State marker properties of niacin skin sensitivity in ultra-high risk groups for psychosis - An optical reflection spectroscopy study

Kerstin Langbein, Ulrike Schmidt, Stephan Schack, Natalie J Biesel, Maria Rudzok, G Paul Amminger, Maximus Berger, Heinrich Sauer, Stefan Smesny

Journal article  |  2018  |  Schizophrenia Research

Youth Depression Alleviation-Augmentation with an anti-inflammatory agent (YoDA-A): protocol and rationale for a placebo-controlled randomized trial of rosuvastatin and aspirin

Amelia L Quinn, Olivia M Dean, Christopher G Davey, Melissa Kerr, Susy M Harrigan, Sue M Cotton, Andrew M Chanen, Seetal Dodd, Aswin Ratheesh, G Paul Amminger, Mark Phelan, Amber Williams, Andrew Mackinnon, Francesco Giorlando, Shelley Baird, Simon Rice, Melissa O'Shea, Miriam R Schaefer, Edward Mullen, Sarah Hetrick, et al.

Journal article  |  2018  |  Early Intervention in Psychiatry

Impaired mismatch negativity to frequency deviants in individuals at ultra-high risk for psychosis, and preliminary evidence for further

Suzie Lavoie, Bradley N Jack, Oren Griffiths, Ayaka Ando, Paul Amminger, Anthony Couroupis, Aidan Jago, Connie Markulev, Patrick D McGorry, Barnaby Nelson, Andrea Polari, Hok Pan Yuen, Thomas J Whitford

Journal article  |  2018  |  Schizophrenia Research

White matter connectivity disruptions in early and chronic schizophrenia

MA Di Biase, VL Cropley, BT Baune, J Olver, GP Amminger, C Phassouliotis, C Bousman, PD McGorry, I Everall, C Pantelis, A Zalesky

Journal article  |  2017  |  Psychological Medicine

Usefulness of the CAPE-P15 for detecting people at ultra-high risk for psychosis: Psychometric properties and cut-off values

Akvile Bukenaite, Jan Stochl, Nilufar Mossaheb, Miriam R Schafer, Claudia M Klier, Jana Becker, Monika Schloegelhofer, Konstantinos Papageorgiou, Angel L Montejo, Debra A Russo, Peter B Jones, Jesus Perez, G Paul Amminger

Journal article  |  2017  |  Schizophrenia Research

Effects of omega-3 PUFA on immune markers in adolescent individuals at ultra-high risk for psychosis - Results of the randomized controlled Vienna omega-3 study

Stefan Smesny, Berko Milleit, Miriam R Schaefer, Jana Hesse, Monika Schloegelhofer, Kerstin Langbein, Uta-Christina Hipler, Maximus Berger, David R Cotter, Heinrich Sauer, Patrick D McGorry, G Paul Amminger

Journal article  |  2017  |  Schizophrenia Research

Are current labeling terms suitable for people who are at risk of psychosis?

Sung-Wan Kim, Andrea Polari, Fritha Melville, Bridget Moller, Jae-Min Kim, Paul Amminger, Helen Herrman, Patrick McGorry, Barnaby Nelson

Journal article  |  2017  |  Schizophrenia Research

PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia

MA Di Biase, A Zalesky, G O'keefe, L Laskaris, BT Baune, CS Weickert, J Olver, PD McGorry, GP Amminger, B Nelson, AM Scott, I Hickie, R Banati, F Turkheimer, M Yaqub, IP Everall, C Pantelis, V Cropley

Journal article  |  2017  |  Translational Psychiatry

Omega-6 to omega-3 polyunsaturated fatty acid ratio and subsequent mood disorders in young people with at-risk mental states: a 7-year longitudinal study

ME Berger, S Smesny, S-W Kim, CG Davey, S Rice, Z Sarnyai, M Schloegelhofer, MR Schafer, M Berk, PD McGorry, GP Amminger

Journal article  |  2017  |  Translational Psychiatry

Longitudinal determinants of client treatment satisfaction in an intensive first-episode psychosis treatment programme

Lisa N Cruz, Emily Kline, Larry J Seidman, Kyle S Minor, Eric C Meyer, Carina Iati, Suzanna V Zimmet, Michelle Friedman-Yakoobian

Journal article  |  2017  |  Early Intervention in Psychiatry

Confirmatory Factor Analysis of the Gotland Male Depression Scale in an Australian Community Sample

Simon M Rice, Helen M Aucote, Anne Maria Moeller-Leimkuehler, G Paul Amminger

Journal article  |  2017  |  European Journal of Psychological Assessment

Using clinical information to make individualized prognostic predictions in people at ultra high risk for psychosis

Andrea Mechelli, Ashleigh Lin, Stephen Wood, Patrick McGorry, Paul Amminger, Stefania Tognin, Philip McGuire, Jonathan Young, Barnaby Nelson, Alison Yung

Journal article  |  2017  |  Schizophrenia Research

Negative Psychosis Prevention Trials Reply

Patrick D McGorry, Barnaby Nelson, Paul Amminger

Journal article  |  2017  |  JAMA Psychiatry

Men's perceived barriers to help seeking for depression: Longitudinal findings relative to symptom onset and duration

Simon M Rice, Helen M Aucote, Alexandra G Parker, Mario Alvarez-Jimenez, Kate M Filia, G Paul Amminger

Journal article  |  2017  |  Journal of Health Psychology

Novel biotherapies are needed in youth mental health

G Paul Amminger, Maximus Berger, Simon M Rice, Christopher G Davey, Miriam R Schafer, Patrick D McCorry

Journal article  |  2017  |  Australasian Psychiatry

Erythrocyte glutathione levels as long-term predictor of transition to psychosis

S Lavoie, M Berger, M Schloegelhofer, MR Schaefer, S Rice, S-W Kim, J Hesse, PD McGorry, S Smesny, GP Amminger

Journal article  |  2017  |  Translational Psychiatry

Substance use in youth at risk for psychosis

R Carney, AR Yung, GP Amminger, T Bradshaw, N Glozier, DF Hermens, IB Hickie, E Killackey, P McGorry, C Pantelis, SJ Wood, R Purcell

Journal article  |  2017  |  Schizophrenia Research

ALLOSTATIC LOAD IS ASSOCIATED WITH POSITIVE SYMPTOMS IN SCHIZOPHRENIA AND FIRST-EPISODE PSYCHOSIS AND DECREASES WITH ANTIPSYCHOTIC THERAPY

Maximus Berger, Robert-Paul Juster, Sabine Westphal, G Paul Amminger, Johann Steiner, Zoltan Sarnyai

Conference Proceedings  |  2017  |  SCHIZOPHRENIA BULLETIN

POLYUNSATURATED FATTY ACID BIOSTATUS, PHOSPHOLIPASE A(2) ACTIVITY AND BRAIN WHITE MATTER MICROSTRUCTURE ACROSS ADOLESCENCE

Robert K McNamara, Philip R Szeszko, Stefan Smesny, Toshikazu Ikuta, Pamela Derosse, Frederic M Vaz, Berko Milleit, Uta-Christina Hipler, Cornelia Wiegand, Jana Hesse, G Paul Amminger, Anil K Malhotra, Bart D Peters

Journal article  |  2017  |  Neuroscience

Effect of omega-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders The NEURAPRO Randomized Clinical Trial

Patrick D McGorry, Barnaby Nelson, Connie Markulev, Hok Pan Yuen, Miriam R Schaefer, Nilufar Mossaheb, Monika Schloegelhofer, Stephan Smesny, Ian B Hickie, Gregor Emanuel Berger, Eric YH Chen, Lieuwe de Haan, Dorien H Nieman, Merete Nordentoft, Anita Riecher-Rossler, Swapna Verma, Andrew Thompson, Alison Ruth Yung, G Paul Amminger

Journal article  |  2017  |  JAMA Psychiatry

Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for Psychosis

Jessica A Hartmann, Patrick D McGorry, Stefanie J Schmidt, G Paul Amminger, Hok Pan Yuen, Connie Markulev, Gregor E Berger, Eric YH Chen, Lieuwe de Haan, Ian B Hickie, Suzie Lavoie, Meredith J McHugh, Nilufar Mossaheb, Dorien H Nieman, Merete Nordentoft, Anita Riecher-Roessler, Miriam R Schafer, Monika Schloegelhofer, Stefan Smesny, Andrew Thompson, et al.

Journal article  |  2017  |  Psychotherapy and Psychosomatics

Cortisol awakening response in patients with schizophrenia, first-episode psychosis and at-risk mental states: a meta-analysis

M Berger, A Kraeuter, D Romanik, P Malouf, G Amminger, Z Sarnyai

Conference Proceedings  |  2016  |  European Neuropsychopharmacology

The Frequency Mismatch Negativity in Individuals at Ultra-High Risk for Psychosis: Effect of Omega-3 Fatty Acids Treatment

Suzie Lavoie, Thomas Whitford, Paul Amminger, Ayaka Ando, Anthony Couroupis, Aidan Jago, Connie Markulev, Barnaby Nelson, Andrea Polari, Patrick McGorry

Conference Proceedings  |  2016  |  EARLY INTERVENTION IN PSYCHIATRY

Characterising neurocognitive impairment in young people with major depression: state, trait or scar?

Kelly Allott, Caroline Fisher, Paul Amminger, Joanne Goodall, Sarah Hetrick

Conference Proceedings  |  2016  |  EARLY INTERVENTION IN PSYCHIATRY

Trauma, Stress Reactivity and Prediction of Outcome in the Ultra High Risk Population: Data from the Neurapro-E Study

Sarah Bendall, Barnaby Nelson, Andrew Thompson, Hok Pan Yuen, Lieuwe De Haan, Dorien Nieman, Suzie Lavoie, Paul Amminger, Connie Markulev, Lisa Phillips, Alison Yung, Patrick McGorry

Conference Proceedings  |  2016  |  EARLY INTERVENTION IN PSYCHIATRY

NEURAPRO-E: A Multicentre Randomized Controlled Trial of Omega-3 Fatty Acids and Cognitive-Behavioural Case Management for Patients at Ultra High Risk of Schizophrenia and Other Psychotic Disorders

Patrick D McGorry, B Nelson, C Markulev, AR Yung, G Berger, L de Haan, A Riecher-Rossler, M Nordentoft, EY Chen, S Verma, Ian Hickie, GP Amminger

Conference Proceedings  |  2016  |  EARLY INTERVENTION IN PSYCHIATRY

Cortisol Awakening Response in Patients with Schizophrenia, First-Episode Psychosis and At-Risk Mental States: A Meta-Analysis

Maximus Berger, Ann-Katrin Kraeuter, Daria Romanik, Peter Malouf, G Paul Amminger, Zoltan Sarnyai

Conference Proceedings  |  2016  |  EARLY INTERVENTION IN PSYCHIATRY

Characterizing neurocognitive impairment in young people with major depression: state, trait, or scar?

Kelly Allott, Caroline A Fisher, Gunther Paul Amminger, Joanne Goodall, Sarah Hetrick

Journal article  |  2016  |  Brain and Behavior

Beyond Psychosis Risk: Introduction to a Broad at Risk Mental State

Jessica Hartmann, Barnaby Nelson, Paul Amminger, Andrew Chanen, Aswin Ratheesh, Christopher Davey, Patrick McGorry

Conference Proceedings  |  2016  |  EARLY INTERVENTION IN PSYCHIATRY

Duration of Untreated Psychosis and Cognitive Functioning in First-Episode Psychosis: A Systematic Review and Meta-Analysis

Kelly Allott, David Fraguas, Cali Bartholomeusz, Covadonga Martinez, Cassandra Wannan, Christos Pantelis, Paul Amminger, Celso Arango, Emma Parrish, Marta Rapado-Castro

Conference Proceedings  |  2016  |  EARLY INTERVENTION IN PSYCHIATRY

Opening the Black Box of Cognitive Behavioural Case Management in Young People at Ultra-High Risk for Psychosis

Jessica Hartmann, Patrick D McGorry, G Paul Amminger, Hok Pan Yuen, Lieuwe de Haan, Stefan Smesny, Connie Markulev, Gregor E Berger, Miriam M Schafer, Merete Nordentoft, Anita Riecher-Rossler, Barnaby Nelson

Conference Proceedings  |  2016  |  EARLY INTERVENTION IN PSYCHIATRY

The Identification of Clinical Trajectories in the Ultra High Risk for Psychosis Population

Andrea Polari, Suzie Lavoie, Hok Pan Yuen, Paul Amminger, Gregor Berger, Dorien Nieman, Eric Chen, Lieuwe deHaan, Merete Nordentoft, Anita Riecher-Roessler, Patrick McGorry, Barnaby Nelson

Conference Proceedings  |  2016  |  EARLY INTERVENTION IN PSYCHIATRY

Indicated prevention with long-chain polyunsaturated omega-3 fatty acids in patients with 22q11DS genetically at high risk for psychosis. Protocol of a randomized, double-blind, placebo-controlled treatment trial

Marco Armando, Franco De Crescenzo, Stefano Vicari, Maria Cristina Digilio, Maria Pontillo, Francesco Papaleo, G Paul Amminger

Journal article  |  2016  |  Early Intervention in Psychiatry

Low Levels Of Cell Membrane Eicosapentanoic Acid (EPA) And Docosahexaenoic Acid (DHA) Are Associated With Depression At Long-Term Follow-Up In The Vienna Omega-3 Study

Monika Schloegelhofer, Maximus Berger, Miriam R Schaefer, Claudia M Klier, Patrick D McGorry, G Paul Amminger

Conference Proceedings  |  2016  |  EARLY INTERVENTION IN PSYCHIATRY

A prospective cohort study of depression course, functional disability, and NEET status in help-seeking young adults

Bridianne O'Dea, Rico SC Lee, Patrick D McGorry, Ian B Hickie, Jan Scott, Daniel F Hermens, Arnstein Mykeltun, Rosemary Purcell, Eoin Killackey, Christos Pantelis, G Paul Amminger, Nicholas Glozier

Journal article  |  2016  |  Social Psychiatry and Psychiatric Epidemiology

Prediction of transition from ultra-high risk to first-episode psychosis using a probabilistic model combining history, clinical assessment and fatty-acid biomarkers

SR Clark, BT Baune, KO Schubert, S Lavoie, S Smesny, SM Rice, MR Schaefer, F Benninger, M Feucht, CM Klier, PD McGorry, GP Amminger

Journal article  |  2016  |  Translational Psychiatry

Differential expression of the inflammation marker IL12p40 in the at-risk mental state for psychosis: a predictor of transition to psychotic disorder?

Melanie Focking, Patrick Dicker, Lorna M Lopez, Mary Cannon, Miriam R Schafer, Patrick D McGorry, Stefan Smesny, David R Cotter, G Paul Amminger

Journal article  |  2016  |  BMC Psychiatry

Cortisol awakening response in patients with psychosis: Systematic review and meta-analysis

Maximus Berger, Ann Katrin Kraeuter, Daria Romanik, Peter Malouf, G Paul Amminger, Zoltan Sarnyai

Journal article  |  2016  |  Neuroscience & Biobehavioral Reviews

White matter integrity in individuals at ultra-high risk for psychosis: a systematic review and discussion of the role of polyunsaturated fatty acids

Nandita Vijayakumar, Cali Bartholomeusz, Thomas Whitford, Daniel F Hermens, Barnaby Nelson, Simon Rice, Sarah Whittle, Christos Pantelis, Patrick McGorry, Miriam R Schafer, G Paul Amminger

Journal article  |  2016  |  BMC Psychiatry

Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA-F): A randomized, double-blind, placebo-controlled treatment trial

Simon M Rice, Ian B Hickie, Alison R Yung, Andrew Mackinnon, Michael Berk, Christopher Davey, Daniel F Hermens, Sarah E Hetrick, Alexandra G Parker, Miriam R Schafer, Patrick D McGorry, G Paul Amminger

Journal article  |  2016  |  Early Intervention in Psychiatry

A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis

Justin Davis, Harris Eyre, Felice N Jacka, Seetal Dodd, Olivia Dean, Sarah McEwen, Monojit Debnath, John McGrath, Michael Maes, Paul Amminger, Patrick D McGorry, Christos Pantelis, Michael Berk

Journal article  |  2016  |  Neuroscience & Biobehavioral Reviews

Associations of obsessive-compulsive symptoms with clinical and neurocognitive features in schizophrenia according to stage of illness

Sung-Wan Kim, Jeong-Hoon Lee, Jae-Min Kim, Il-Seon Shin, Michael Y Hwang, G Paul Amminger, Barnaby Nelson, Michael Berk, Patrick McGorry, Jin-Sang Yoon

Conference Proceedings  |  2016  |  INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Disrupting GluR2-GAPDH Interaction Affects Axon and Dendrite Development

Min Jhon, Paul Amminger, Michael Berk, Jae-Min Kim, Sung-Wan Kim, Claudia M Klier, Simon Rice, Miriam R Schaefer, Stefan Smesny

Conference Proceedings  |  2016  |  INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Association between erythrocyte membrane fatty acids and psychopathology in individuals at ultra-high risk for psychosis

Min Jhon, Paul Amminger, Michael Berk, Jae-Min Kim, Sung-Wan Kim, Claudia M Klier, Simon Rice, Miriam R Schaefer, Stefan Smesny

Conference Proceedings  |  2016  |  INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Relationship between Erythrocyte Fatty Acid Composition and Psychopathology in the Vienna Omega-3 Study

Sung-Wan Kim, Min Jhon, Jae-Min Kim, Stefan Smesny, Simon Rice, Michael Berk, Claudia M Klier, Patrick D McGorry, Miriam R Schaefer, G Paul Amminger

Journal article  |  2016  |  PLOS ONE

Niacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for Psychosis

Gregor E Berger, Stefan Smesny, Miriam R Schaefer, Berko Milleit, Kerstin Langbein, Uta-Christina Hipler, Christine Milleit, Claudia M Klier, Monika Schloegelhofer, Magdalena Holub, Ingrid Holzer, Michael Berk, Patrick D McGorry, Heinrich Sauer, G Paul Amminger

Journal article  |  2016  |  PLOS ONE

Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk A Meta-analytical Stratification

Paolo Fusar-Poli, Marco Cappucciati, Stefan Borgwardt, Scott W Woods, Jean Addington, Barnaby Nelson, Dorien H Nieman, Daniel R Stahl, Grazia Rutigliano, Anita Riecher-Roessler, Andor E Simon, Masafumi Mizuno, Tae Young Lee, Jun Soo Kwon, May ML Lam, Jesus Perez, Szabolcs Keri, Paul Amminger, Sibylle Metzler, Wolfram Kawohl, et al.

Journal article  |  2016  |  JAMA Psychiatry

Correlates of electroencephalographic resting states and erythrocyte membrane docosahexaenoic and eicosapentaenoic acid levels in individuals at ultra-high risk of psychosis

Suzie Lavoie, Thomas J Whitford, Franz Benninger, Martha Feucht, Sung-Wan Kim, Claudia M Klier, Robert K McNamara, Simon Rice, Miriam R Schaefer, G Paul Amminger

Journal article  |  2016  |  Australian & New Zealand Journal of Psychiatry

Demographic and clinical characteristics of young people seeking help at youth mental health services: baseline findings of the Transitions Study

Rosemary Purcell, Anthony F Jorm, Ian B Hickie, Alison R Yung, Christos Pantelis, G Paul Amminger, Nick Glozier, Eoin Killackey, Lisa J Phillips, Stephen J Wood, Susy Harrigan, Andrew Mackinnon, Elizabeth Scott, Daniel F Hermens, Adam J Guastella, Amanda Kenyon, Laura Mundy, Alissa Nichles, Antoinette Scaffidi, Daniela Spiliotacopoulos, et al.

Journal article  |  2015  |  Early Intervention in Psychiatry

Glutamatergic dysfunction linked to energy and membrane lipid metabolism in frontal and anterior cingulate cortices of never treated first-episode schizophrenia patients

Stefan Smesny, Alexander Gussew, Natalie Joan Biesel, Stephan Schack, Mario Walther, Reinhard Rzanny, Berko Milleit, Christian Gaser, Thomas Sobanski, Carl Christoph Schultz, Paul Amminger, Uta-Christina Hipler, Heinrich Sauer, Juergen R Reichenbach

Journal article  |  2015  |  Schizophrenia Research

International Society for Nutritional Psychiatry Research consensus position statement: nutritional medicine in modern psychiatry

Jerome Sarris, Alan C Logan, Tasnime N Akbaraly, G Paul Amminger, Vicent Balanza-Martinez, Marlene P Freeman, Joseph Hibbeln, Yutaka Matsuoka, David Mischoulon, Tetsuya Mizoue, Akiko Nanri, Daisuke Nishi, Natalie Parletta, Drew Ramsey, Julia J Rucklidge, Almudena Sanchez-Villegas, Andrew Scholey, Kuan-Pin Su, Felice N Jacka

Journal article  |  2015  |  World Psychiatry

Associations of hippocampal metabolism and regional brain grey matter in neuroleptic-naive ultra-high-risk subjects and first-episode schizophrenia

Igor Nenadic, Raka Maitra, Soumyajit Basu, Maren Dietzek, Nils Schoenfeld, Carsten Lorenz, Alexander Gussew, G Paul Amminger, Patrick McGorry, Juergen R Reichenbach, Heinrich Sauer, Christian Gaser, Stefan Smesny

Journal article  |  2015  |  European Neuropsychopharmacology

Effects of omega-3 PUFA on the vitamin E and glutathione antioxidant defense system in individuals at ultra-high risk of psychosis

Stefan Smesny, Berko Milleit, Miriam R Schaefer, Uta-Christina Hipler, Christine Milleit, Cornelia Wiegand, Jana Hesse, Claudia M Klier, Magdalena Holub, Ingrid Holzer, Michael Berk, Patrick D McGorry, Heinrich Sauer, G Paul Amminger

Journal article  |  2015  |  Prostaglandins, Leukotrienes and Essential Fatty Acids

Self reported rates of criminal offending and victimization in young people at-risk for psychosis

R Purcell, S Harrigan, N Glozier, GP Amminger, AR Yung

Journal article  |  2015  |  Schizophrenia Research

Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study

G Paul Amminger, Miriam R Schaefer, Monika Schloegelhofer, Claudia M Klier, Patrick D McGorry

Journal article  |  2015  |  Nature Communications

Erythrocyte polyunsaturated fatty acid levels in young people at ultra-high risk for psychotic disorder and healthy adolescent controls

Simon M Rice, Miriam R Schaefer, Claudia Klier, Nilufar Mossaheb, Nandita Vijayakumar, Gunter Paul Amminger

Journal article  |  2015  |  Psychiatry Research

The Beyond Ageing Project Phase 2-a double-blind, selective prevention, randomised, placebo-controlled trial of omega-3 fatty acids and sertraline in an older age cohort at risk for depression: study protocol for a randomized controlled trial

Nicole L Cockayne, Shantel L Duffy, Rosalind Bonomally, Amelia English, Paul G Amminger, Andrew Mackinnon, Helen M Christensen, Sharon L Naismith, Ian B Hickie

Journal article  |  2015  |  Trials

Adolescents at ultra-high risk for psychosis with and without 22q11 deletion syndrome: a comparsion of prodromal psychotic symptoms and general functioning

Marco Armando, Stefano Vicari, Deny Menghini, Maria Cristina Digilio, Maria Pontillo, Maria Laura Pucciarini, Ashleigh Lin, Paul Amminger

Conference Proceedings  |  2015  |  EUROPEAN CHILD & ADOLESCENT PSYCHIATRY

Longitudinal sex differences of externalising and internalising depression symptom trajectories: Implications for assessment of depression in men from an online study

Simon M Rice, Barry J Fallon, Helen M Aucote, AnneMaria Moeller-Leimkuehler, Matt S Treeby, G Paul Amminger

Journal article  |  2015  |  International Journal of Social Psychiatry

Oxidative Markers for Prediction of Transition to Psychosis From the Clinical High-risk State

B Baune, S Clark, O Schubert, S Rice, N Vijayakumar, M Schaefer, P McGorry, P Amminger

Conference Proceedings  |  2015  |  European Psychiatry

ELEVATED INFLAMMATORY MARKERS IN INDIVIDUALS WHO TRANSITION TO PSYCHOSIS FROM THE AT- RISK-MENTAL-STATE.

DR Cotter, Mary Cannon, Melanie Foecking, Pat Dicker, Lorna Lopez, Patrick McGorry, Miriam R Schaefer, Paul Amminger

Conference Proceedings  |  2015  |  SCHIZOPHRENIA BULLETIN

Associations of obsessive-compulsive symptoms with clinical and neurocognitive features in schizophrenia according to stage of illness

Sung-Wan Kim, Bo-Ok Jeong, Jae-Min Kim, Ii-Seon Shin, Michael Y Hwang, G Paul Amminger, Barnaby Nelson, Michael Berk, Patrick McGorry, Jin-Sang Yoon

Journal article  |  2015  |  Psychiatry Research

Nutritional medicine as mainstream in psychiatry

Jerome Sarris, Alan C Logan, Tasnime N Akbaraly, G Paul Amminger, Vicent Balanza-Martinez, Marlene P Freeman, Joseph Hibbeln, Yutaka Matsuoka, David Mischoulon, Tetsuya Mizoue, Akiko Nanri, Daisuke Nishi, Drew Ramsey, Julia J Rucklidge, Almudena Sanchez-Villegas, Andrew Scholey, Kuan-Pin Su, Felice N Jacka

Journal article  |  2015  |  The Lancet Psychiatry

Transitions Study of predictors of illness progression in young people with mental ill health: study methodology

R Purcell, AF Jorm, IB Hickie, AR Yung, C Pantelis, GP Amminger, N Glozier, E Killackey, L Phillips, SJ Wood, A Mackinnon, E Scott, A Kenyon, L Mundy, A Nichles, A Scaffidi, D Spiliotacopoulos, L Taylor, JPY Tong, S Wiltink, et al.

Journal article  |  2015  |  Early Intervention in Psychiatry

Emotion recognition in unaffected first-degree relatives of individuals with first-episode schizophrenia

Kelly A Allott, Simon Rice, Cali F Bartholomeusz, Claudia Klier, Monika Schloegelhofer, Miriam R Schaefer, G Paul Amminger

Journal article  |  2015  |  Schizophrenia Research

Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids

GP Amminger, A Mechelli, S Rice, S-W Kim, CM Klier, RK McNamara, M Berk, PD McGorry, MR Schaefer

Journal article  |  2015  |  Translational Psychiatry

Relationship between amygdala volume and emotion recognition in adolescents at ultra-high risk for psychosis

Cali F Bartholomeusz, Sarah L Whittle, Eleanor Pilioussis, Kelly Allott, Simon Rice, Miriam R Schaefer, Christos Pantelis, G Paul Amminger

Journal article  |  2014  |  Psychiatry Research: Neuroimaging

The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial

Christopher G Davey, Andrew M Chanen, Sue M Cotton, Sarah E Hetrick, Melissa J Kerr, Michael Berk, Olivia M Dean, Kally Yuen, Mark Phelan, Aswin Ratheesh, Miriam R Schaefer, G Paul Amminger, Alexandra G Parker, Danijela Piskulic, Susy Harrigan, Andrew J Mackinnon, Ben J Harrison, Patrick D McGorry

Journal article  |  2014  |  Trials

Longer-term follow-up in the Vienna omega-3 psychosis prevention trial

G Paul Amminger, Monika Schloegelhofer, Claudia Klier, Patrick McGorry, Miriam Schaefer

Conference Proceedings  |  2014  |  EARLY INTERVENTION IN PSYCHIATRY

Impact of obsessive compulsive symptoms on clinical features and neurocognitive functioning in schizophrenia according to the stage of illness

Sung-Wan Kim, Yo-Han Lee, Jeong-Hoon Lee, Jae-Min Kim, Il-Seon Shin, G Paul Amminger, Barnaby Nelson, Michael Berk, Patrick McGorry, Jin-Sang Yoon

Conference Proceedings  |  2014  |  EARLY INTERVENTION IN PSYCHIATRY

Correlates of EEG resting states with erythrocyte membrane omega-3 fatty acid levels and psychopathological symptoms in individuals at ultra-high risk for psychosis

Suzie Lavoie, Franz Benninger, Martha Feucht, Claudia M Klier, Miriam R Schaefer, G Paul Amminger

Conference Proceedings  |  2014  |  EARLY INTERVENTION IN PSYCHIATRY

Biomarkers and clinical staging in psychiatry

Patrick McGorry, Matcheri Keshavan, Sherilyn Goldstone, Paul Amminger, Kelly Allott, Michael Berk, Suzie Lavoie, Christos Pantelis, Alison Yung, Stephen Wood, Ian Hickie

Journal article  |  2014  |  World Psychiatry

Perinatal Use of Aripiprazole Plasma Levels, Placental Transfer, and Child Outcome in 3 New Cases

Elmar Windhager, Sung-Wan Kim, Alois Saria, Katharina Zauner, Paul G Amminger, Claudia M Klier

Journal article  |  2014  |  Journal of Clinical Psychopharmacology

Online and social networking interventions for the treatment of depression in young people: a systematic review.

Simon M Rice, Joanne Goodall, Sarah E Hetrick, Alexandra G Parker, Tamsyn Gilbertson, G Paul Amminger, Christopher G Davey, Patrick D McGorry, John Gleeson, Mario Alvarez-Jimenez

Journal article  |  2014  |  Journal of Medical Internet Research

BACKGROUND: Major depression accounts for the greatest burden of all diseases globally. The peak onset of depression occurs betwee..

Relationship between membrane fatty acids and cognitive symptoms and information processing in individuals at ultra-high risk for psychosis

Sung-Wan Kim, Miriam R Schaefer, Claudia M Klier, Michael Berk, Simon Rice, Kelly Allott, Cali F Bartholomeusz, Sarah L Whittle, Eleanor Pilioussis, Christos Pantelis, Patrick D McGorry, G Paul Amminger

Journal article  |  2014  |  Schizophrenia Research

Impact of comorbid anxiety disorders and obsessive-compulsive disorder on 24-month clinical outcomes of bipolar I disorder

Sung-Wan Kim, Lesley Berk, Jayashri Kulkarni, Seetal Dodd, Anthony de Castella, Paul B Fitzgerald, G Paul Amminger, Michael Berk

Journal article  |  2014  |  Journal of Affective Disorders

Metabolic changes in first-episode early-onset schizophrenia with second-generation antipsychotics

Brian O'Donoghue, Miriam R Schaefer, Jana Becker, Konstantinos Papageorgiou, G Paul Amminger

Journal article  |  2014  |  Early Intervention in Psychiatry

Polyunsaturated fatty acids in emerging psychosis: a safer alternative?

Monika Schloegelhofer, G Paul Amminger, Miriam R Schaefer, Paolo Fusar-Poli, Stefan Smesny, Pat McGorry, Gregor Berger, Nilufar Mossaheb

Journal article  |  2014  |  Early Intervention in Psychiatry

Identifying Gene-Environment Interactions in Schizophrenia: Contemporary Challenges for Integrated, Large-scale Investigations

Jim van Os, Bart P Rutten, Inez Myin-Germeys, Philippe Delespaul, Wolfgang Viechtbauer, Catherine van Zelst, Richard Bruggeman, Ulrich Reininghaus, Craig Morgan, Robin M Murray, Marta Di Forti, Philip McGuire, Lucia R Valmaggia, Matthew J Kempton, Charlotte Gayer-Anderson, Kathryn Hubbard, Stephanie Beards, Simona A Stilo, Adanna Onyejiaka, Francois Bourque, et al.

Journal article  |  2014  |  Schizophrenia Bulletin

Sexual Trauma Increases the Risk of Developing Psychosis in an Ultra High-Risk "Prodromal" Population

Andrew D Thompson, Barnaby Nelson, Hok Pan Yuen, Ashleigh Lin, Guenter Paul Amminger, Patrick D McGorry, Stephen J Wood, Alison R Yung

Journal article  |  2014  |  Schizophrenia Bulletin

FATTY ACID MARKERS OF PSYCHOSIS PROGRESSION AND TREATMENT RESPONSE

Paul Amminger

Conference Proceedings  |  2014  |  SCHIZOPHRENIA RESEARCH

AXIS I AND AXIS II DISORDERS IN YOUNG PEOPLE AT ULTRA-HIGH RISK OF DEVELOPING A PSYCHOTIC DISORDER: A LONG-TERM FOLLOW UP STUDY

Anneliese E Spiteri-Staines, Alison R Yung, Paul G Amminger, Stephen Wood, Ashleigh Lin, Emily Li, Barnaby Nelson

Conference Proceedings  |  2014  |  SCHIZOPHRENIA RESEARCH

SUBTHRESHOLD INTERVENTION TO REDUCE THE IMPACT OF EMERGING PSYCHOSIS AND RISK FOR STAGE PROGRESSION: RECENT AND FUTURE CLINICAL TRIALS

Patrick McGorry, Barnaby Nelson, Lisa Phillips, Paul Amminger, Alison Yung

Conference Proceedings  |  2014  |  SCHIZOPHRENIA RESEARCH

ARE THE GLUTAMATERGIC DYSFUNCTION AND MEMBRANE LIPID HYPOTHESIS LINKED? A COMBINED 1H/31P-MR-SPECTROSCOPY STUDY IN NEVER TREATED ACUTE ONSET SCHIZOPHRENIA

Stefan Smesny, Alexander Gussew, Igor Nenadic, Natalie Joan Biesel, Carl Christoph Schultz, Paul Amminger, Heinrich Sauer

Conference Proceedings  |  2014  |  SCHIZOPHRENIA RESEARCH

Emotion recognition as a predictor of transition to a psychotic disorder in ultra-high risk participants

Kelly A Allott, Miriam R Schaefer, Andrew Thompson, Barnaby Nelson, Sarah Bendall, Cali F Bartholomeusz, Hok Pan Yuen, Patrick D McGorry, Monika Schloegelhofer, Andreas Bechdolf, G Paul Amminger

Journal article  |  2014  |  Schizophrenia Research

Omega-3 fatty acid supplementation changes intracellular phospholipase A(2) activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis

S Smesny, B Milleit, U-C Hipler, C Milleit, MR Schaefer, CM Klier, M Holub, I Holzer, GE Berger, M Otto, I Nenadic, M Berk, PD McGorry, H Sauer, GP Amminger

Journal article  |  2014  |  Molecular Psychiatry

Omega-3 fatty acid supplementation changes intracellular phospholipase A 2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis

S Smesny, B Milleit, UC Hipler, C Milleit, MR Schäfer, CM Klier, M Holub, I Holzer, GE Berger, M Otto, I Nenadic, M Berk, PD Mcgorry, H Sauer, GP Amminger

Journal article  |  2014  |  Molecular Psychiatry

Delayed sleep onset in depressed young people

Nicholas Glozier, Bridianne O'Dea, Patrick D McGorry, Christos Pantelis, Gunter Paul Amminger, Daniel F Hermens, Rosemary Purcell, Elizabeth Scott, Ian B Hickie

Journal article  |  2014  |  BMC Psychiatry

Duration of untreated psychosis in a high-income versus a low-and middle-income region

Nilufar Mossaheb, Monika Schloegelhofer, Rainer M Kaufmann, Sonja Werneck-Rohrer, Sonja Zehetmayer, Farah Malik, Rabia Khawar, Haroon Rasheed Chaudry, G Paul Amminger, Claudia M Klier, Harald Aschauer

Journal article  |  2013  |  Australian and New Zealand Journal of Psychiatry

Biased Reporting of Results in Patients at Ultra-High Risk of Psychosis Reply

Patrick D McGorry, Alison R Yung, Barnaby Nelson, G Paul Amminger, Lisa J Phillips

Journal article  |  2013  |  Journal of Clinical Psychiatry

Is basic self-disturbance in ultra-high risk for psychosis ("prodromal') patients associated with borderline personality pathology?

Barnaby Nelson, Andrew Thompson, Andrew M Chanen, Guenther Paul Amminger, Alison R Yung

Journal article  |  2013  |  Early Intervention in Psychiatry

Long-term Follow-up of a Group at Ultra High Risk ("Prodromal") for Psychosis The PACE 400 Study

Barnaby Nelson, Hok Pan Yuen, Stephen J Wood, Ashleigh Lin, Daniela Spiliotacopoulos, Annie Bruxner, Christina Broussard, Magenta Simmons, Debra L Foley, Warrick J Brewer, Shona M Francey, G Paul Amminger, Andrew Thompson, Patrick D McGorry, Alison R Yung

Journal article  |  2013  |  JAMA Psychiatry

Effect of omega-3 fatty acids for indicated prevention of young patients at risk for psychosis: When do they begin to be effective?

Nilufar Mossaheb, Miriam R Schaefer, Monika Schloegelhofer, Claudia M Klier, Susan M Cotton, Patrick D McGorry, G Paul Amminger

Journal article  |  2013  |  Schizophrenia Research

Omega-3 Fatty Acid Supplementation in Adolescents With Borderline Personality Disorder and Ultra-High Risk Criteria for Psychosis: A Post Hoc Subgroup Analysis of a Double-Blind, Randomized Controlled Trial

G Paul Amminger, Andrew M Chanen, Susanne Ohmann, Claudia M Klier, Nilufar Mossaheb, Andreas Bechdolf, Barnaby Nelson, Andrew Thompson, Patrick D McGorry, Alison R Yung, Miriam R Schaefer

Journal article  |  2013  |  Canadian Journal of Psychiatry

Affect recognition and functioning in putatively prodromal individuals

G Paul Amminger, Kelly Allott, Monika Schloegelhofer, Andrew Thompson, Andreas Bechdolf, Barnaby Nelson, Nilufar Mossaheb, Miriam R Schaefer

Journal article  |  2013  |  Schizophrenia Research

SOCIAL COGNITION DEFICITS IN CLINICAL 'AT RISK' FOR PSYCHOSIS AND FIRST-EPISODE PSYCHOSIS POPULATIONS

Andrew Thompson, Cali Bartholomeusz, Alicia Papas, Kelly Allot, Paul Amminger, Barnaby Nelson, Stephen Wood, Alison R Yung

Conference Proceedings  |  2013  |  AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Effects of NRG1 and DAOA genetic variation on transition to psychosis in individuals at ultra-high risk for psychosis

CA Bousman, AR Yung, C Pantelis, JA Ellis, RA Chavez, B Nelson, A Lin, SJ Wood, GP Amminger, D Velakoulis, PD McGorry, IP Everall, DL Foley

Journal article  |  2013  |  Translational Psychiatry

Randomized Controlled Trial of Interventions for Young People at Ultra-High Risk of Psychosis: Twelve-Month Outcome

Patrick D McGorry, Barnaby Nelson, Lisa J Phillips, Hok Pan Yuen, Shona M Francey, Annette Thampi, Gregor E Berger, G Paul Amminger, Magenta B Simmons, Daniel Kelly, Andrew D Thompson, Alison R Yung

Journal article  |  2013  |  Journal of Clinical Psychiatry

Long-chain omega-3 fatty acids and psychotic disorders

N Mossaheb, M Schloegelhofer, MR Schaefer, P Fusar-Poli, S Smesny, P McGorry, G Berger, GP Amminger

Book Chapter  |  2013

Decreased nervonic acid levels in erythrocyte membranes predict psychosis in help-seeking ultra-high-risk individuals

GP Amminger, MR Schaefer, CM Klier, J-M Slavik, I Holzer, M Holub, S Goldstone, TJ Whitford, PD McGorry, M Berk

Journal article  |  2012  |  Molecular Psychiatry

Facial and vocal affect perception in people at ultra-high risk of psychosis, first-episode schizophrenia and healthy controls

G Paul Amminger, Miriam R Schaefer, Claudia M Klier, Monika Schloegelhofer, Nilufar Mossaheb, Andrew Thompson, Andreas Bechdolf, Kelly Allott, Patrick D McGorry, Barnaby Nelson

Journal article  |  2012  |  Early Intervention in Psychiatry

The Community Assessment of Psychic Experience (CAPE) questionnaire as a screening-instrument in the detection of individuals at ultra-high risk for psychosis

Nilufar Mossaheb, Jana Becker, Miriam R Schaefer, Claudia M Klier, Monika Schloegelhofer, Konstantinos Papageorgiou, G Paul Amminger

Journal article  |  2012  |  Schizophrenia Research

Social cognition in clinical "at risk" for psychosis and first episode psychosis populations

Andrew Thompson, Alicia Papas, Cali Bartholomeusz, Kelly Allott, G Paul Amminger, Barnaby Nelson, Stephen Wood, Alison Yung

Journal article  |  2012  |  Schizophrenia Research

Whither the Attenuated Psychosis Syndrome?

Alison R Yung, Scott W Woods, Stephan Ruhrmann, Jean Addington, Frauke Schultze-Lutter, Barbara A Cornblatt, G Paul Amminger, Andreas Bechdolf, Max Birchwood, Stefan Borgwardt, Tyrone D Cannon, Lieuwe de Haan, Paul French, Paolo Fusar-Poli, Matcheri Keshavan, Joachim Klosterkoetter, Jun Soo Kwon, Patrick D McGorry, Philip McGuire, Masafumi Mizuno, et al.

Journal article  |  2012  |  Schizophrenia Bulletin

Changes in serum lipid levels in early-onset schizophrenia during treatment with second generation antipsychotics

Brian O'Donoghue, Miriam Schaefer, Jana Becker, Konstantinos Papageorgiou, Paul Amminger

Conference Proceedings  |  2012  |  EARLY INTERVENTION IN PSYCHIATRY

A comparison of general functioning and prodromal positive and negative psychotic symptoms between adolescents at clinical ultra high risk with and without 22Q11 deletion syndrome

Marco Armando, Stefano Vicari, Paolo Girardi, Maria Pontillo, Riccardo Saba, Ashleigh Lin, Paul Amminger

Conference Proceedings  |  2012  |  EARLY INTERVENTION IN PSYCHIATRY

Affect recognition and functioning in putatively prodromal individuals

G Paul Amminger, Kelly Allott, Monika Schloegelhofer, Andrew Thompson, Andreas Bechdolf, Barnaby Nelson, Nilufar Mossaheb, Claudia M Klier, Miriam R Schaefer

Conference Proceedings  |  2012  |  EARLY INTERVENTION IN PSYCHIATRY

Emotion Recognition in Individuals at Clinical High-Risk for Schizophrenia

G Paul Amminger, Miriam R Schaefer, Konstantinos Papageorgiou, Claudia M Klier, Monika Schloegelhofer, Nilufar Mossaheb, Sonja Werneck-Rohrer, Barnaby Nelson, Patrick D McGorry

Journal article  |  2012  |  Schizophrenia Bulletin

Adolescents at ultra-high risk for psychosis with and without 22q11 deletion syndrome: A comparison of prodromal psychotic symptoms and general functioning

Marco Armando, Paolo Girardi, Stefano Vicari, Deny Menghini, Maria Cristina Digilio, Maria Pontillo, Riccardo Saba, Luigi Mazzone, Ashleigh Lin, Claudia M Klier, Miriam R Schafer, G Paul Amminger

Journal article  |  2012  |  Schizophrenia Research

Frontal delta power associated with negative symptoms in ultra-high risk individuals who transitioned to psychosis

Suzie Lavoie, Miriam R Schaefer, Thomas J Whitford, Franz Benninger, Martha Feucht, Claudia M Klier, Hok Pan Yuen, Christos Pantelis, Patrick D McGorry, G Paul Amminger

Journal article  |  2012  |  Schizophrenia Research

Review: limited evidence from two small trials suggests no improvement in ASD symptoms with short term ω-3 supplementation.

G Paul Amminger, Miriam R Schäfer

Journal article  |  2012  |  Evidence Based Mental Health

RANDOMIZED CONTROLLED TRIAL OF INTERVENTIONS FOR YOUNG PEOPLE AT ULTRA-HIGH RISK OF PSYCHOSIS: 12-MONTH OUTCOME

Patrick D McGorry, B Nelson, LJ Phillips, HP Yuen, S Francey, A Thampi, G Berger, GP Amminger, M Simmons, K Baker, D Kelly, M Ross, A Thompson, AR Yung

Conference Proceedings  |  2012  |  Schizophrenia Research

TRAUMA AND RISK OF DEVELOPING PSYCHOSIS IN A HIGH CLINICAL RISK POPULATION: RESULTS FROM A MEDIUM TO LONG TERM FOLLOW-UP STUDY

Andrew Thompson, Barnaby Nelson, Hok Pan Yuen, Paul G Amminger, Patrick D McGorry, Ashleigh Lin, Stephen Wood, Alison R Yung

Conference Proceedings  |  2012  |  Schizophrenia Research

HOW EFFECTIVE ARE OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF THE PSYCHOSIS PRODROME?

Paul G Amminger, CM Klier, B Nelson, AR Yung, HP Yuen, PD McGorry, MR Schafer

Conference Proceedings  |  2012  |  Schizophrenia Research

Road to full recovery: longitudinal relationship between symptomatic remission and psychosocial recovery in first-episode psychosis over 7.5 years

M Alvarez-Jimenez, JF Gleeson, LP Henry, SM Harrigan, MG Harris, E Killackey, S Bendall, GP Amminger, AR Yung, H Herrman, HJ Jackson, PD McGorry

Journal article  |  2012  |  Psychological Medicine

Structural abnormalities in the cuneus associated with Herpes Simplex Virus (type 1) infection in people at ultra high risk of developing psychosis

Thomas J Whitford, Stephen J Wood, Alison Yung, Luca Cocchi, Gregor Berger, Martha E Shenton, Marek Kubicki, Lisa Phillips, Dennis Velakoulis, Robert H Yolken, Christos Pantelis, Patrick McGorry, G Paul Amminger

Journal article  |  2012  |  Schizophrenia Research

Polyunsaturated Fatty Acids in Emerging Psychosis

Nilufar Mossaheb, Monika Schloegelhofer, Miriam R Schaefer, Paolo Fusar-Poli, Stefan Smesny, Pat McGorry, Gregor Berger, G Paul Amminger

Journal article  |  2012  |  Current Pharmaceutical Design

Rationale and First Results of Developing At-Risk (Prodromal) Criteria for Bipolar Disorder

A Bechdolf, A Ratheesh, SJ Wood, T Tecic, P Conus, B Nelson, SM Cotton, AM Chanen, GP Amminger, S Ruhrmann, F Schultze-Lutter, J Klosterkoetter, P Fusar Polij, AR Yung, M Berk, PD McGorry

Journal article  |  2012  |  Current Pharmaceutical Design

Neuroprotective Effects of Low-dose Lithium in Individuals at Ultra-high Risk for Psychosis. A Longitudinal MRI/MRS Study

Gregor E Berger, Stephen J Wood, Margaret Ross, Clare A Hamer, R Mark Wellard, Gaby Pell, Lisa Phillips, Barnaby Nelson, G Paul Amminger, Alison R Yung, Graeme Jackson, Dennis Velakoulis, Christos Pantelis, Husseini Manji, Patrick D McGorry

Journal article  |  2012  |  Current Pharmaceutical Design

Update on Omega-3 Polyunsaturated Fatty Acids in Early-Stage Psychotic Disorders

G Paul Amminger, Patrick D McGorry

Journal article  |  2012  |  Neuropsychopharmacology

Phospholipase A(2) activity in first episode schizophrenia: Associations with symptom severity and outcome at week 12

Stefan Smesny, Christina Kunstmann, Sebastian Kunstmann, Ingo Willhardt, Juergen Lasch, Rachel A Yotter, Tina-Marie Proffitt, Melissa Kerr, Conny Marculev, Berko Milleit, Christine Milleit, Igor Nenadic, Paul Amminger, Patrick D Mcgorry, Heinrich Sauer, Gregor E Berger

Journal article  |  2011  |  The World Journal of Biological Psychiatry

Early detection and intervention for psychoses

N Mossaheb, GP Amminger

Journal article  |  2011  |  Journal fur Neurologie, Neurochirurgie und Psychiatrie

Outcome in early-onset schizophrenia revisited: Findings from the Early Psychosis Prevention and Intervention Centre long-term follow-up study

G Paul Amminger, Lisa P Henry, Susy M Harrigan, Meredith G Harris, Mario Alvarez-Jimenez, Helen Herrman, Henry J Jackson, Patrick D McGorry

Journal article  |  2011  |  Schizophrenia Research

Age of onset and timing of treatment for mental and substance use disorders: implications for preventive intervention strategies and models of care

Patrick D McGorry, Rosemary Purcell, Sherilyn Goldstone, G Paul Amminger

Journal article  |  2011  |  Current Opinion in Psychiatry

Randomized Controlled Trial of Interventions for Young People at Ultra High Risk for Psychosis: 6-Month Analysis

Alison R Yung, Lisa J Phillips, Barnaby Nelson, Shona M Francey, Hok PanYuen, Magenta B Simmons, Margaret L Ross, Daniel Kelly, Kathryn Baker, G Paul Amminger, Gregor Berger, Andrew D Thompson, Annette Thampi, Patrick D McGorry

Journal article  |  2011  |  Journal of Clinical Psychiatry

Prediction of a single psychotic episode: A 7.5-year, prospective study in first-episode psychosis

M Alvarez-Jimenez, JF Gleeson, LP Henry, SM Harrigan, MG Harris, GP Amminger, E Killackey, AR Yung, H Herrman, HJ Jackson, PD McGorry

Journal article  |  2011  |  Schizophrenia Research

Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors

M Berk, F Kapczinski, AC Andreazza, OM Dean, F Giorlando, M Maes, M Yuecel, CS Gama, S Dodd, B Dean, PVS Magalhaes, P Amminger, P McGorry, GS Malhi

Journal article  |  2011  |  Neuroscience and Biobehavioral Reviews

A preliminary evaluation of the validity of at-risk criteria for bipolar disorders in help-seeking adolescents and young adults

Andreas Bechdolf, Barnaby Nelson, Sue M Cotton, Andrew Chanen, Andrew Thompson, Jonathan Kettle, Phillippe Conus, G Paul Amminger, Alison R Yung, Michael Berk, Patrick D McGorry

Journal article  |  2010  |  Journal of Affective Disorders

From neuroprogression to neuroprotection: implications for clinical care

Michael Berk, Philippe Conus, Flavio Kapczinski, Ana C Andreazza, Murat Yucel, Stephen J Wood, Christos Pantelis, Gin S Malhi, Seetal Dodd, Andreas Bechdolf, G Paul Amminger, Ian B Hickie, Patrick D McGorry

Journal article  |  2010  |  Medical Journal of Australia

The EPPIC Follow-Up Study of First-Episode Psychosis: Longer-Term Clinical and Functional Outcome 7 Years After Index Admission

Lisa P Henry, G Paul Amminger, Meredith G Harris, Hok Pan Yuen, Susy M Harrigan, Amy L Prosser, Orli S Schwartz, Simone E Farrelly, Helen Herrman, Henry J Jackson, Patrick D McGorry

Journal article  |  2010  |  Journal of Clinical Psychiatry

Experience of trauma and conversion to psychosis in an ultra-high-risk (prodromal) group

A Bechdolf, A Thompson, B Nelson, S Cotton, MB Simmons, GP Amminger, S Leicester, SM Francey, C McNab, H Krstev, A Sidis, PD McGorry, AR Yung

Journal article  |  2010  |  Acta Psychiatrica Scandinavica

Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders

G Paul Amminger, Miriam R Schäfer, Konstantinos Papageorgiou, Claudia M Klier, Sue M Cotton, Susan M Harrigan, Andrew Mackinnon, Patrick D McGorry, Gregor E Berger

Journal article  |  2010  |  Archives of General Psychiatry

Long-Chain omega-3 Fatty Acids for Indicated Prevention of Psychotic Disorders A Randomized, Placebo-Controlled Trial

G Paul Amminger, Miriam R Schafer, Konstantinos Papageorgiou, Claudia M Klier, Sue M Cotton, Susan M Harrigan, Andrew Mackinnon, Patrick D McGorry, Gregor E Berger

Journal article  |  2010  |  Archives of General Psychiatry

Intervention in Individuals at Ultra-High Risk for Psychosis: A Review and Future Directions

Patrick D McGorry, Barnaby Nelson, G Paul Amminger, Andreas Bechdolf, Shona M Francey, Gregor Berger, Anita Riecher-Roessler, Joachim Klosterkoetter, Stephan Ruhrmann, Frauke Schultze-Lutter, Merete Nordentoft, Ian Hickie, Philip McGuire, Michael Berk, Eric YH Chen, Matcheri S Keshavan, Alison R Yung

Journal article  |  2009  |  Journal of Clinical Psychiatry

Does disturbance of self underlie social cognition deficits in schizophrenia and other psychotic disorders?

Barnaby Nelson, Louis A Sass, Andrew Thompson, Alison R Yung, Shona M Francey, G Paul Amminger, Patrick D McGorry

Journal article  |  2009  |  Early Intervention in Psychiatry

The International Study on General Practitioners and Early Psychosis (IGPS).

Andor E Simon, Helen Lester, Lynda Tait, Emanuel Stip, Paul Roy, Gretchen Conrad, Jennifer Hunt, Irvin Epstein, Tor K Larsen, Paul Amminger, David Holub, Barbora Wenigová, Mark Turner, Gregor E Berger, Colin O'Donnell, Daniel Umbricht

Journal article  |  2009  |  Schizophrenia Research

BACKGROUND: In much of the world, general practitioners (GPs) are the health professionals most frequently initially contacted whe..

Ethyl-Eicosapentaenoic Acid in First-Episode Psychosis. A IH-MRS Study (vol 33, pg 2467, 2008)

Gregor E Berger, Stephen J Wood, R Mark Wellard, Tina M Proffitt, Mirabel McConchie, G Paul Amminger, Graeme D Jackson, Dennis Velakoulis, Christos Pantelis, Patrick D McGorry

Journal article  |  2009  |  Neuropsychopharmacology

Clinical characteristics of first-episode schizophrenia

L HENRY, P MCGORRY, G Harris, G AMMINGER

Book Chapter  |  2009

Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: study design and baseline characteristics

Lisa J Phillips, Barnaby Nelson, Hok Pan Yuen, Shona M Francey, Magenta Simmons, Carrie Stanford, Margaret Ross, Daniel Kelly, Kathryn Baker, Philippe Conus, Paul Amminger, Francois Trumpler, Yang Yun, Michelle Lim, Catharine McNab, Alison R Yung, Patrick D McGorry

Journal article  |  2009  |  Australian and New Zealand Journal of Psychiatry

Dosing Quetiapine in Drug-Naive First-Episode Psychosis: A Controlled, Double-Blind, Randomized, Single-Center Study Investigating Efficacy, Tolerability, and Safety of 200 mg/day vs. 400 mg/day of Quetiapine Fumarate in 141 Patients Aged 15 to 25 Years

Gregor E Berger, Tina-Marie Proffitt, Mirabel McConchie, Melissa Kerr, Connie Markulev, Hok Pan Yuen, Colin O'Donnell, Dan Lubman, Andrea Polari, Stephen Wood, G Paul Amminger, Patrick D McGorry

Journal article  |  2008  |  Journal of Clinical Psychiatry

Ethyl-eicosapentaenoic acid in first-episode psychosis. A 1H-MRS study

Gregor E Berger, Stephen J Wood, R Mark Wellard, Tina M Proffitt, Mirabel McConchie, G Paul Amminger, Graeme D Jackson, Dennis Velakoulis, Christos Pantelis, Patrick D McGorry

Journal article  |  2008  |  Neuropsychopharmacology

Reply

GP Amminger, SM Harrigan

Journal article  |  2008  |  Biological Psychiatry

Back to the future - Predicting and reshaping the course of psychotic disorder

Patrick D McGorry, Alison R Yung, Andreas Bechdolf, Paul Amminger

Journal article  |  2008  |  Archives of General Psychiatry

Ethyl-eicosapentaenoic acid in first-episode psychosis: A randomized, placebo-controlled trial

Gregor E Berger, Tina-Marie Proffitt, Mirabel McConchie, HokPan Yuen, Stephen J Wood, G Paul Amminger, Warrick Brewer, Patrick D McGorry

Journal article  |  2007  |  Journal of Clinical Psychiatry

PACE: a specialised service for young people at risk of psychotic disorders

Alison R Yung, Patrick D McGorry, Shona M Francey, Barnaby Nelson, Kathryn Baker, Lisa J Phillips, Gregor Berger, G Paul Amminger

Journal article  |  2007  |  Medical Journal of Australia

Age of onset of mental disorders: a review of recent literature

Ronald C Kessler, G Paul Amminger, Sergio Aguilar-Gaxiola, Jordi Alonso, Sing Lee, T Bedirhan Uestuen

Journal article  |  2007  |  Current Opinion in Psychiatry

Antibodies to infectious agents in individuals at ultra-high risk for psychosis

G Paul Amminger, Patrick D McGorry, Gregor E Berger, Darryl Wade, Alison R Yung, Lisa J Phillips, Susy M Harrigan, Shona M Francey, Robert H Yolken

Journal article  |  2007  |  Biological Psychiatry

Neuroprotection in emerging psychotic disorders

Gregor Berger, Margaret Dell'Olio, Paul Amminger, Barbara Cornblatt, Lisa Phillips, Alison Yung, Yung Yan, Michael Berk, Patrick McGorry

Journal article  |  2007  |  Early Intervention in Psychiatry

Omega-3 fatty acids supplementation in children with autism: A double-blind randomized, placebo-controlled pilot study

G Paul Amminger, Gregor E Berger, Miriam R Schaefer, Claudia Klier, Max H Friedrich, Martha Feucht

Journal article  |  2007  |  Biological Psychiatry

Early Psychosis Prevention and Intervention Centre long-term follow-up study of first-episode psychosis: methodology and baseline characteristics

Lisa P Henry, Meredith G Harris, G Paul Amminger, Hok Pan Yuen, Susy M Harrigan, Martin Lambert, Philippe Conus, Orli Schwartz, Amy Prosser, Simone Farrelly, Rosemary Purcell, Helen Herrman, Henry J Jackson, Patrick D McGorry

Journal article  |  2007  |  Early Intervention in Psychiatry

PACE: a specialised service for young people at risk of psychotic disorders.

AR Yung, PD McGorry, SM Francey, B Nelson, K Baker, LJ Phillips, G Berger, GP Amminger

Journal article  |  2007  |  Medical Journal of Australia

Früherkennung psychotischer Störungen / Early detection of psychotic disorders

MR Schafer, CM Klier, K Papageorgiou, MH Friedrich, G AMMINGER

Journal article  |  2007  |  Neuropsychiatrie

[Early detection of psychotic disorders].

Miriam R Schäfer, Claudia M Klier, Konstantinos Papageorgiou, Max H Friedrich, G Paul Amminger

Journal article  |  2007  |  Neuropsychiatrie

UNLABELLED: Over the last decade there has been considerable interest in early intervention in schizophrenia and other psychotic d..

Treated incidence of first-episode psychosis in the catchment area of EPPIC between 1997 and 2000

GP Amminger, MG Harris, P Conus, M Lambert, KS Elkins, H-P Yuen, PD McGorry

Journal article  |  2006  |  Acta Psychiatrica Scandinavica

Early-onset of symptoms predicts conversion to non-affective psychosis in ultra-high risk individuals

GP Amminger, S Leicester, AR Yung, LJ Phillips, GE Berger, SM Francey, HP Yuen, PD McGorry

Journal article  |  2006  |  Schizophrenia Research

Bioactive lipids in schizophrenia

Gregor E Berger, Stefan Smesny, G Paul Amminger

Journal article  |  2006  |  International Review of Psychiatry

[Early recognition and intervention for schizophrenia].

N Mossaheb, G Wiesegger, GP Amminger, S Kasper, J Tauscher

Journal article  |  2006  |  Der Nervenarzt

Studies dealing with the prodromal stage of schizophrenia point to the possibility of early detection and early intervention. Majo..

International clinical practice guidelines for early psychosis

J Addington, GP Amminger, A Barbato, S Catts, E Chen, S Chhim, SA Chong, J Cullberg, J Edwards, L Grosso, M Louza, M Hambrecht, M Keshavan, JO Johannessen, DL Johnson, S Lewis, J Lieberman, W MacEwan, A Malla, R May, et al.

Conference Proceedings  |  2005  |  British Journal of Psychiatry

International clinical practice guidelines for early psychosis: international early psychosis association writing group

undefined Addington, G AMMINGER, undefined Barbato, undefined Catts, undefined Chen, undefined Chhim, A Chong, undefined Cullberg, undefined Edwards, undefined Grosso, undefined Louza, undefined Hambrecht, undefined Keshavan, O Johannessen, L Johnson, undefined Lewis, undefined Lieberman, undefined MacEwan, undefined Malla, undefined May, et al.

Journal article  |  2005  |  British Journal of Psychiatry

The Prodromal Course

G AMMINGER, S LEICESTER, S FRANCEY, P MCGORRY

Book Chapter  |  2005

Prodromal Research and Interventions

G Paul Amminger, Claudia KLIER

Book Chapter  |  2004

Estimating cognitive deterioration in schizophrenia [3] (multiple letters)

GP Amminger, J Edwards, PD McGorry, RMG Norman

Journal article  |  2002  |  British Journal of Psychiatry

Untitled

J Edwards, SM Harrigan, D McGorry, GP Amminger

Journal article  |  2002  |  Psychological Medicine

Duration of untreated psychosis and cognitive deterioration in first-episode schizophrenia

GP Amminger, J Edwards, WJ Brewer, S Harrigan, PD McGorry

Journal article  |  2002  |  Schizophrenia Research

Duration of untreated psychosis (DUP) and outcome in schizophrenia

J EDWARDS, S HARRIGAN, P MCGORRY, G AMMINGER

Journal article  |  2002  |  Psychological Medicine

Estimating cognitive deterioration in first-episode schizophrenia

G AMMINGER, J EDWARDS, P MCGORRY

Journal article  |  2002  |  British Journal of Psychiatry

Untreated initial psychosis.

PD McGorry, SM Harrigan, P Amminger, R Norman, A Malla

Journal article  |  2001  |  American Journal of Psychiatry

Premorbid performance IQ deficit in schizophrenia.

GP Amminger, M Schlögelhofer, T Lehner, S Looser Ott, MH Friedrich, HN Aschauer

Journal article  |  2000  |  Acta Psychiatrica Scandinavica

OBJECTIVE: Performance IQ (PIQ) is often lower than verbal IQ (VIQ) in schizophrenic patients. Whether PIQ < VIQ precedes psychoti..

The New York High-Risk Project: comorbidity for axis I disorders is preceded by childhood behavioral disturbance.

GP Amminger, S Pape, D Rock, SA Roberts, E Squires-Wheeler, C Kestenbaum, L Erlenmeyer-Kimling

Journal article  |  2000  |  The Journal of Nervous and Mental Disease

The relationship between childhood behavioral disturbance and comorbidity for adult psychiatric disorders has not been sufficientl..

Relationship between childhood behavioral disturbance and later schizophrenia in the New York High-Risk Project.

GP Amminger, S Pape, D Rock, SA Roberts, SL Ott, E Squires-Wheeler, C Kestenbaum, L Erlenmeyer-Kimling

Journal article  |  1999  |  American Journal of Psychiatry

OBJECTIVE: An association between childhood behavioral disturbance and adulthood schizophrenia has been seen previously in retrosp..

The New York High-Risk Project: social and general intelligence in children at risk for schizophrenia.

SL Ott, S Spinelli, D Rock, S Roberts, GP Amminger, L Erlenmeyer-Kimling

Journal article  |  1998  |  Schizophrenia Research

UNLABELLED: Social deficits, as well as low performance on intelligence tests, are known early symptoms of schizophrenia. We studi..

On the existence of early warning signs of schizophrenic syndromes among children and adolescents

F Resch, P Parzer, P Amminger, S Hedemann, RH Brunner, E Koch

Journal article  |  1998  |  Neurology Psychiatry and Brain Research

Premorbid adjustment and remission of positive symptoms in first-episode psychosis.

GP Amminger, F Resch, R Mutschlechner, MH Friedrich, E Ernst

Journal article  |  1997  |  European Child & Adolescent Psychiatry

The impact of premorbid social and intellectual functioning in childhood and early adolescence on the developmental course of schi..

["Primary and secondary negative symptoms: a reliable differentiation?" Comment on the contribution by W. Barnett et al].

GP Amminger, B Kirkpatrick

Journal article  |  1997  |  Der Nervenarzt

Negative and positive dimensions of schizotypal personality disorder.

E Squires-Wheeler, D Friedman, GP Amminger, A Skodol, S Looser-Ott, S Roberts, K Pape, L Erlenmeyer-Kimling

Conference Proceedings  |  1997  |  Journal of Personality Disorders

The positive (perceptual-cognitive) and negative (social-interpersonal) dimensions of schizotypal personality traits were examined..

Psychopharmakatherapie im Kindesalter

Guenter Amminger

Book Chapter  |  1997

Kinderpsychiatrische Krankheitsbilder

Guenter Amminger

Book Chapter  |  1997

Diagnosis of headache in childhood and adolescence: a study in 437 patients.

C Wöber-Bingöl, C Wöber, A Karwautz, C Vesely, C Wagner-Ennsgraber, GP Amminger, K Zebenholzer, J Geldner, W Baischer, B Schuch

Journal article  |  1995  |  Cephalalgia

We investigated whether the criteria for idiopathic headache published by the International Headache Society (IHS) are useful in c..

Ursachen und Rehabilitation schwerer akzidentieller Cerebralläsionen im Kindesalter

Guenter Amminger, G Wörgötter, E Berger

Book Chapter  |  1995

Social competence and adolescent psychosis.

GP Amminger, R Mutschlechner, F Resch

Journal article  |  1994  |  British Journal of Psychiatry

Investigation of basic symptoms in children and adolescents

F Resch, B Schuch, GP Amminger

Journal article  |  1993  |  Neurology Psychiatry and Brain Research

Natural killer cell function in adolescent and adult schizophrenic patients

F Resch, GP Amminger, H Aschauer, C Müller, C Zielinski

Journal article  |  1993  |  European Child & Adolescent Psychiatry

Lymphozytäre Phänotypen bei Adoleszentenpsychosen.

F Resch, G Paul Amminger, HN Aschauer, M Eibl

Book Chapter  |  1993

[Side effects of clozapine in therapy of psychotic disorders in adolescents. A retrospective clinical study].

GP Amminger, F Resch, J Reimitz, MH Friedrich

Journal article  |  1992  |  Zeitschrift fur Kinder- und Jugendpsychiatrie

A retrospective study was conducted of 53 consecutive inpatients (through 1990) with psychotic disorders. The patients were betwee..

A Case Report of Cannabidiol Treatment of a Crohn's Disease Patient With Anxiety Disorder.

Claudia M Klier, Charlotte de Gier, Anna Felnhofer, Clarissa Laczkovics, Paul G Amminger

Journal article  |  Journal of Clinical Psychopharmacology